Skip to main content

Table 1 Baseline characteristics for acute phase and maintenance phase samples

From: Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study

 

Acute phase sample

(n = 717)

Maintenance phase sample

(n = 459)

Gender, n (%)

 Female

308 (43.0)

200 (43.6)

 Male

409 (57.0)

259 (56.4)

Age, mean (SD)

42.9 (14.0)

42.7 (14.2)

BMI, mean (SD)

24.4 (4.9)

24.3 (4.8)

UC-DAI, mean (SD)

 Stool frequency (range: 0–3)

1.7 (0.8)

1.6 (0.8)

 Rectal bleeding severity (range: 0–3)

1.3 (0.7)

1.2 (0.7)

 Mucosal appearance (range: 0–3)

1.9 (0.5)

1.9 (0.5)

 Physician global assessment (range: 0–3)

1.6 (0.5)

1.6 (0.5)

 Total score (range: 0–12)

6.6 (1.6)

6.3 (1.5)

SF-12v2, mean (SD)

 Physical functioning

46.3 (9.1)

46.2 (9.1)

 Role physical

43.8 (7.9)

44.5 (7.5)

 Bodily pain

43.5 (9.1)

43.7 (8.7)

 General health

41.5 (10.1)

41.1 (9.8)

 Vitality

46.8 (9.5)

47.2 (8.9)

 Social functioning

42.4 (9.3)

43.1 (8.9)

 Role emotional

41.9 (9.6)

41.8 (9.4)

 Mental health

44.2 (9.4)

44.4 (9.0)

 PCS

44.9 (7.7)

45.0 (7.6)

 MCS

43.1 (9.2)

43.5 (8.9)

SIBDQ, mean (SD)

 Bowel symptoms (range: 3–21)

12.6 (3.1)

12.8 (3.1)

 Systemic symptoms (range: 2–14)

8.9 (2.6)

9.1 (2.5)

 Emotional function (range: 3–21)

12.8 (3.9)

13.1 (3.8)

 Social function (range: 2–14)

8.9 (3.0)

9.2 (2.9)

 Total score (range: 10–70)

43.2 (10.6)

44.1 (10.4)

WPAI:UC, mean (SD); range (0–100)

 Absenteeism

13.3 (24.0)

12.3 (22.2)

 Presenteeism

36.1 (24.5)

32.7 (22.8)

 Overall work impairment

42.2 (28.2)

39.1 (26.6)

 Activity impairment

41.5 (25.6)

38.9 (24.7)

  1. BMI body mass index, MCS mental component summary, PCS physical component summary, SD standard deviation, SF-12v2 SF-12v2 Health Survey, SIBDQ Short Inflammatory Bowel Disease Questionnaire, UC-DAI Ulcerative Colitis Disease Activity Index, WPAI:UC Work Productivity and Activity Impairment questionnaire for ulcerative colitis